Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$79.12
1.041.33%
al cierre: -
$79.30
0.180.23%
After hour: Oct 17, 7:57 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Colgate-Palmolive Co ha un obiettivo di prezzo di consenso pari a $96.9, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da JP Morgan, B of A Securities y UBS il octubre 10, 2025, octubre 8, 2025 y octubre 8, 2025. Con un obiettivo di prezzo medio di $89.33 tra le JP Morgan, B of A Securities y UBS, c'è un implicito 12.65% upside per Colgate-Palmolive Co da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
JP Morgan
B of A Securities
UBS
Piper Sandler
Goldman Sachs
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Colgate-Palmolive
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/10/2025 | 10.97% | JP Morgan | $95 → $88 | Maintains | Overweight | |||
10/08/2025 | 10.97% | B of A Securities | $98 → $88 | Maintains | Buy | |||
10/08/2025 | 16.02% | UBS | $99 → $92 | Maintains | Buy | |||
10/03/2025 | 5.93% | Piper Sandler | → $84 | Assumes | → Neutral | |||
10/02/2025 | 14.75% | Goldman Sachs | $106 → $91 | Maintains | Buy | |||
10/01/2025 | 3.4% | Barclays | $87 → $82 | Maintains | Equal-Weight | |||
09/25/2025 | 0.88% | Wells Fargo | $83 → $80 | Maintains | Underweight | |||
08/04/2025 | 32.41% | Citigroup | $108 → $105 | Maintains | Buy | |||
08/04/2025 | 19.8% | JP Morgan | $99 → $95 | Maintains | Overweight | |||
08/04/2025 | 21.06% | Morgan Stanley | $104 → $96 | Maintains | Overweight | |||
08/04/2025 | 4.67% | Wells Fargo | $88 → $83 | Maintains | Underweight | |||
07/25/2025 | 24.84% | JP Morgan | $103 → $99 | Maintains | Overweight | |||
07/17/2025 | 33.67% | UBS | $109 → $106 | Maintains | Buy | |||
07/15/2025 | 9.71% | Barclays | $86 → $87 | Maintains | Equal-Weight | |||
04/28/2025 | 36.19% | Citigroup | $103 → $108 | Maintains | Buy | |||
04/28/2025 | 29.89% | JP Morgan | $95 → $103 | Maintains | Overweight | |||
04/17/2025 | 37.45% | UBS | $105 → $109 | Maintains | Buy | |||
04/11/2025 | 8.45% | Barclays | $89 → $86 | Maintains | Equal-Weight | |||
04/11/2025 | 19.8% | JP Morgan | $99 → $95 | Maintains | Overweight | |||
04/02/2025 | 10.97% | Wells Fargo | $83 → $88 | Maintains | Underweight | |||
03/31/2025 | 34.93% | Piper Sandler | $108 → $107 | Maintains | Overweight | |||
03/27/2025 | 12.23% | Barclays | $83 → $89 | Maintains | Equal-Weight | |||
03/14/2025 | 24.84% | JP Morgan | $97 → $99 | Maintains | Overweight | |||
02/03/2025 | 22.32% | JP Morgan | $103 → $97 | Maintains | Overweight | |||
02/03/2025 | 26.1% | UBS | $104 → $100 | Maintains | Buy | |||
02/03/2025 | 17.28% | Stifel | $95 → $93 | Maintains | Hold | |||
02/03/2025 | 23.58% | RBC Capital | $101 → $98 | Maintains | Sector Perform | |||
02/03/2025 | 32.41% | Raymond James | $110 → $105 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 31.15% | Morgan Stanley | $111 → $104 | Maintains | Overweight | |||
01/29/2025 | 27.36% | RBC Capital | $101 → $101 | Reiterates | Sector Perform → Sector Perform | |||
01/17/2025 | 19.8% | Stifel | $101 → $95 | Maintains | Hold | |||
01/17/2025 | 4.67% | Barclays | $96 → $83 | Maintains | Equal-Weight | |||
01/16/2025 | 31.15% | UBS | $112 → $104 | Maintains | Buy | |||
01/16/2025 | 29.89% | JP Morgan | $109 → $103 | Maintains | Overweight | |||
01/08/2025 | 26.1% | TD Cowen | $110 → $100 | Maintains | Buy | |||
01/07/2025 | 4.67% | Wells Fargo | $92 → $83 | Maintains | Underweight | |||
01/06/2025 | 41.24% | Piper Sandler | $121 → $112 | Maintains | Overweight | |||
10/28/2024 | 41.24% | UBS | $122 → $112 | Maintains | Buy | |||
10/28/2024 | 16.02% | Wells Fargo | $100 → $92 | Maintains | Underweight | |||
10/28/2024 | 38.71% | TD Cowen | $115 → $110 | Maintains | Buy | |||
10/28/2024 | 27.36% | Stifel | $105 → $101 | Downgrade | Buy → Hold | |||
10/11/2024 | 43.76% | JP Morgan | $113 → $114 | Maintains | Overweight | |||
09/24/2024 | 52.59% | Piper Sandler | → $121 | Initiates | → Overweight | |||
09/16/2024 | 26.1% | Wells Fargo | → $100 | Downgrade | Equal-Weight → Underweight | |||
09/09/2024 | 37.45% | Deutsche Bank | $107 → $109 | Downgrade | Buy → Hold | |||
09/04/2024 | 53.85% | UBS | $119 → $122 | Maintains | Buy | |||
07/30/2024 | 45.02% | TD Cowen | $110 → $115 | Maintains | Buy | |||
07/30/2024 | 29.89% | Bernstein | $100 → $103 | Maintains | Market Perform | |||
07/29/2024 | 34.93% | Deutsche Bank | $104 → $107 | Maintains | Buy | |||
07/29/2024 | 39.97% | Morgan Stanley | $103 → $111 | Maintains | Overweight | |||
07/29/2024 | 21.06% | Barclays | $91 → $96 | Maintains | Equal-Weight | |||
07/26/2024 | — | HSBC | — | Downgrade | Buy → Hold | |||
07/24/2024 | 19.8% | Jefferies | $103 → $95 | Downgrade | Buy → Hold | |||
07/23/2024 | 38.71% | TD Cowen | → $110 | Initiates | → Buy | |||
07/22/2024 | 32.41% | Stifel | $95 → $105 | Maintains | Buy | |||
07/19/2024 | 14.75% | Barclays | $85 → $91 | Maintains | Equal-Weight | |||
07/18/2024 | 33.67% | Evercore ISI Group | $100 → $106 | Maintains | Outperform | |||
07/17/2024 | 31.15% | Deutsche Bank | $98 → $104 | Maintains | Buy | |||
07/10/2024 | 41.24% | Citigroup | $103 → $112 | Maintains | Buy | |||
07/10/2024 | 38.71% | B of A Securities | $100 → $110 | Maintains | Buy | |||
07/10/2024 | 22.32% | Wells Fargo | $92 → $97 | Maintains | Equal-Weight | |||
06/24/2024 | 37.45% | Exane BNP Paribas | → $109 | Initiates | → Outperform | |||
05/28/2024 | 29.89% | Morgan Stanley | $101 → $103 | Maintains | Overweight | |||
05/15/2024 | 34.93% | Argus Research | $97 → $107 | Maintains | Buy | |||
04/30/2024 | 7.19% | Barclays | $84 → $85 | Maintains | Equal-Weight | |||
04/29/2024 | 16.02% | Wells Fargo | $90 → $92 | Maintains | Equal-Weight | |||
04/29/2024 | 19.8% | Stifel | $94 → $95 | Maintains | Buy | |||
04/29/2024 | 26.1% | B of A Securities | $90 → $100 | Maintains | Buy | |||
04/29/2024 | 19.8% | RBC Capital | $88 → $95 | Maintains | Sector Perform | |||
04/16/2024 | 26.1% | Citigroup | $95 → $100 | Maintains | Buy | |||
04/12/2024 | 5.93% | Barclays | $82 → $84 | Maintains | Equal-Weight | |||
04/10/2024 | 18.54% | Stifel | $89 → $94 | Maintains | Buy | |||
04/08/2024 | 21.06% | Evercore ISI Group | $90 → $96 | Maintains | Outperform | |||
03/01/2024 | 17.28% | Goldman Sachs | → $93 | Reinstates | → Buy | |||
01/29/2024 | 17.28% | Morgan Stanley | $85 → $93 | Maintains | Overweight | |||
01/29/2024 | 19.8% | UBS | $93 → $95 | Maintains | Buy | |||
01/29/2024 | 10.97% | Wells Fargo | $80 → $88 | Maintains | Equal-Weight | |||
01/29/2024 | 14.75% | Raymond James | → $91 | Upgrade | Market Perform → Outperform | |||
01/18/2024 | 13.49% | JP Morgan | $88 → $90 | Maintains | Overweight | |||
01/16/2024 | 3.4% | Barclays | $75 → $82 | Maintains | Equal-Weight | |||
12/15/2023 | 13.49% | B of A Securities | → $90 | Upgrade | Neutral → Buy | |||
11/29/2023 | 10.97% | JP Morgan | $83 → $88 | Maintains | Overweight | |||
11/13/2023 | 9.71% | Jefferies | → $87 | Initiates | → Buy | |||
10/30/2023 | 0.88% | RBC Capital | $79 → $80 | Maintains | Sector Perform | |||
10/30/2023 | 7.19% | Morgan Stanley | $89 → $85 | Maintains | Overweight | |||
10/17/2023 | -5.42% | B of A Securities | $85 → $75 | Maintains | Neutral | |||
10/16/2023 | 2.14% | Stifel | $85 → $81 | Upgrade | Hold → Buy | |||
10/12/2023 | -7.94% | Barclays | $81 → $73 | Maintains | Equal-Weight | |||
10/12/2023 | 2.14% | JP Morgan | $85 → $81 | Maintains | Overweight | |||
10/11/2023 | 7.19% | Citigroup | $92 → $85 | Maintains | Buy | |||
09/22/2023 | 5.93% | HSBC | → $84 | Initiates | → Buy | |||
08/01/2023 | 2.14% | Barclays | $77 → $81 | Maintains | Equal-Weight | |||
07/31/2023 | 4.67% | RBC Capital | → $83 | Reiterates | Sector Perform → Sector Perform | |||
07/31/2023 | 14.75% | Deutsche Bank | $88 → $91 | Maintains | Buy | |||
05/01/2023 | 7.19% | B of A Securities | $80 → $85 | Maintains | Neutral | |||
05/01/2023 | 14.75% | Evercore ISI Group | $85 → $91 | Maintains | Outperform | |||
05/01/2023 | 4.67% | RBC Capital | $82 → $83 | Maintains | Sector Perform | |||
05/01/2023 | 21.06% | Goldman Sachs | $86 → $96 | Maintains | Buy | |||
05/01/2023 | 12.23% | Morgan Stanley | $82 → $89 | Maintains | Overweight | |||
05/01/2023 | 2.14% | Wells Fargo | $76 → $81 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Colgate-Palmolive (CL)?
El último precio objetivo de Colgate-Palmolive (NYSE:CL) fue comunicado por JP Morgan el octubre 10, 2025. La firma de analistas fijó un precio objetivo para $88.00 que espera CL a rise dentro de 12 meses (un posible 10.97% upside). 41 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Colgate-Palmolive (CL)?
La última calificación de analistas para Colgate-Palmolive (NYSE:CL) fue proporcionada por JP Morgan, y Colgate-Palmolive mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Colgate-Palmolive (CL)?
La última revisión al alza de Colgate-Palmolive Co se produjo en enero 29, 2024, cuando Raymond James elevó su precio objetivo a $91. Raymond James anteriormente tenía a market perform para Colgate-Palmolive Co.
¿Cuándo fue la última revisión a la baja de Colgate-Palmolive (CL)?
La última revisión a la baja de Colgate-Palmolive Co se produjo en octubre 28, 2024, cuando Stifel cambió su precio objetivo de $105 a $101 para Colgate-Palmolive Co.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Colgate-Palmolive (CL)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Colgate-Palmolive, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Colgate-Palmolive se registró el octubre 10, 2025, por lo que la próxima calificación estará disponible en torno al octubre 10, 2026.
¿Es correcta la calificación de los analistas sobre Colgate-Palmolive (CL)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Colgate-Palmolive (CL) fue un mantuvo con un precio objetivo de $95.00 a $88.00. El precio actual al que cotiza Colgate-Palmolive (CL) es de $79.30, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.